Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Acorda Therapeutics announces initiation of AMPYRA® proof-of-concept study in patients with post-stroke deficits
A Semiautomatic Method for Multiple Sclerosis Lesion Segmentation on Dual-Echo MR Imaging: Application in a Multicenter Context.
Human endogenous retrovirus W in brain lesions: Rationale for targeted therapy in multiple sclerosis.
The payer's perspective: What is the burden of MS and how should the patient's perspective be integrated in health technology assessment conducted for taking decisions on access to care and treatment?
Fecal Microbiota Transplantation and Its Usage in Neuropsychiatric Disorders.
Efficacy of Polyvalent Human Immunoglobulins in an Animal Model of Neuromyelitis Optica Evoked by Intrathecal Anti-Aquaporin 4 Antibodies.
Mechanism of Action and Clinical Potential of Fingolimod for the Treatment of Stroke.
Predictive and reactive grip force responses to rapid load increases in people with multiple sclerosis.
Placental Stromal Cell Therapy for Experimental Autoimmune Encephalomyelitis: The Role of Route of Cell Delivery.
Effect of teriflunomide on QuantiFERON-TB Gold results.
Improved treatment satisfaction after switching therapy to rituximab in relapsing-remitting MS.
Neonatal Dexamethasone Treatment Exacerbates Hypoxia/Ischemia-Induced White Matter Injury.
Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine.
MRI criteria differentiating asymptomatic PML from new MS lesions during natalizumab pharmacovigilance.
Pediatric multiple sclerosis: Perspectives from adolescents and their families.
Diffusion MRI of the spinal cord: from structural studies to pathology.
Conformational changes associated with L16P and T118M mutations in the membrane embedded PMP22 protein, consequential in CMT-1A.
Multiple sclerosis activated by anti-tumor necrosis factor α (Etanercept) and the genetic risk.
Commentary on: Predictive value of health-related quality of life in progression of disability and depression in persons with multiple sclerosis: a 3-year study.
The Importance of Thrombin in Cerebral Injury and Disease.
Safety and Tolerability of Delayed-Release Dimethyl Fumarate Administered with Interferon Beta or Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis.
Expression of IL-1β in rhesus EAE and MS lesions is mainly induced in the CNS itself.
A Minimally-invasive Blood-derived Biomarker of Oligodendrocyte Cell-loss in Multiple Sclerosis.
A review of the ethics of the use of placebo in clinical trials for relapsing-remitting multiple sclerosis therapeutics.
Money Management Activities in Persons with Multiple Sclerosis.

Pages